Kennedy Capital Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
449,179
+29,842
| +7% | +$92.2K | 0.03% | 478 |
|
|
2025
Q1 | $1.46M | Sell |
419,337
-1,372
| -0.3% | -$4.79K | 0.04% | 466 |
|
|
2024
Q4 | $1.38M | Buy |
420,709
+804
| +0.2% | +$2.63K | 0.03% | 562 |
|
|
2024
Q3 | $1.62M | Sell |
419,905
-37,673
| -8% | -$145K | 0.04% | 543 |
|
|
2024
Q2 | $1.41M | Buy |
457,578
+21,072
| +5% | +$65.1K | 0.03% | 550 |
|
|
2024
Q1 | $1.13M | Buy |
436,506
+49,265
| +13% | +$127K | 0.02% | 611 |
|
|
2023
Q4 | $968K | Sell |
387,241
-5,602
| -1% | -$14K | 0.02% | 588 |
|
|
2023
Q3 | $797K | Hold |
392,843
| – | – | 0.02% | 584 |
|
|
2023
Q2 | $904K | Hold |
392,843
| – | – | 0.02% | 561 |
|
|
2023
Q1 | $1.19M | Buy |
+392,843
| New | +$1.19M | 0.04% | 463 |
|